Nano zinc oxide synthesized using Lactobacillus sp. to study the antibacterial activity against pathogenic microorganisms

Abstract

The pharmaceutical industry is becoming more interested in Lactobacillus-capped ZnONPs (Ls-ZnOPs) as a way to improve the production of nanomedicines. In the current investigation, Lactobacillus species were isolated and characterized from curd samples. Next, ZnONPs capped by Lactobacillus (Ls-ZnONPs) were created. According to the findings, LsZnONPs have the potential to be exploited in the pharmaceutical industry for the production of sustainable nanomedicines. Furthermore, it exhibits strong antibacterial properties against a variety of harmful microbes.